Fiduciary Family Office’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,000	Closed	-$301K	–	183
2024 Q3	$301K	Buy	20,000 +10,000	+100%	+$151K	0.1%	167
2024 Q2	$286K	Hold	10,000	–	–	0.11%	164
2024 Q1	$292K	Buy	+10,000	New	+$292K	0.11%	167